Cancer mortality rates in children show unacceptable inequalities between high and low- and middle-income countries. In the latter, late diagnosis, inadequate access to healthcare facilities, and treatment abandonment are the main hurdles for remission. For over 12 years, My Child Matters program has funded 58 cancer projects in more than 40 low- and middle-income countries, reaching so far over 85,000 children. The goal of this initiative, developed by the Fondation Sanofi Espoir, aims to bring equity so that all children with cancer will have the same chance to heal wherever they are in the world.Read More

This article presents the results of a pilot evaluation on diabetes knowledge and behavior of caregivers and school staff of providing education on diabetes in a school setting. The intervention is based on an educational package co-created by the International Diabetes Federation (IDF), the International Society for Pediatric and Adolescent Diabetes (ISPAD), local partners and Sanofi.
Read More

NCDA Kenya (NCDAK) and NCD Alliance held a workshop on 21-22 March to develop The Advocacy Agenda of People living with NCDs (PLWNCDs) in Kenya. The meeting aimed to consult with PLWNCDs to define a common Advocacy Agenda, explore communications and advocacy needed to further the agenda, and promote among stakeholders meaningful involvement of PLWNCDs.Read More

press releases

Celgene Launches Celgene Cancer Care Links TM to Support Cancer Healthcare Capacity Building in Resource-Constrained Countries

Grant Program Will Help Fund Cancer Care Capability, Delivery and Access Programs 

SUMMIT, NJ, December 5, 2017 – Celgene Corporation (NASDAQ:CELG) today announced the launch of Celgene Cancer Care Links, a new grant program designed to support cancer healthcare capacity building in resource-constrained countries around the world. As part of this program, Celgene will collaborate with medical centers focused on enhancing patient care and building sustainable cancer care systems in resourceconstrained countries. Funding will be provided to approved programs in 2018.
Read More

22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable Diseases

At the 2017 World Economic Forum in Davos, Switzerland, twenty-two leading biopharmaceutical companies launched Access Accelerated, a global initiative to advance access to non-communicable disease (NCD) prevention and care in low and middle income countries.


Access Today: Spotlight On City Cancer Challenge World Cancer Day

Addressing the barriers to non-communicable disease (NCD) prevention, treatment and care requires collective action. That’s why Access Accelerated is working with partners to co-create scalable, sustainable solutions that address multiple barriers and make measurable progress against NCDs.

Access Today: Introducing the Access Accelerated Open Platform

As 2018 comes to a close, we are thrilled to achieve an important milestone for Access Accelerated: the launch of the Access Accelerated Open Platform, which is now available online and as a mobile app.

Access Accelerated and IFPMA hold 2018 UN General Assembly side event

In the days leading up to the third United Nations High-Level Meeting on NCDs, Access Accelerated and IFPMA convened partners and stakeholders at a UN General Assembly side event, Working Together to Translate Words into Action: NCD Prevention, Treatment and Care.



We believe a life not defined by disease is a life of possibility.